Transcriptomic responses to antibiotic exposure in Mycobacterium tuberculosis
Antimicrobial Agents and Chemotherapy · 2024
DOI: 10.1128/aac.01185-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Husain Poonawala und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Transcriptome. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCATS NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Transcriptional responses in bacteria following antibiotic exposure offer insights into antibiotic mechanism of action, bacterial responses, and characterization of antimicrobial resistance. We aimed to define the transcriptional antibiotic response (TAR) in Mycobacterium tuberculosis (Mtb) isolates for clinically relevant drugs by pooling and analyzing Mtb microarray and RNA-seq data sets. We generated 99 antibiotic transcription profiles across 17 antibiotics, with 76% of profiles generated using 3–24 hours of antibiotic exposure and 49% within one doubling of the WHO antibiotic critical concentration. TAR genes were time-dependent, and largely specific to the antibiotic mechanism of action. TAR signatures performed well at predicting antibiotic exposure, with the area under the receiver operating curve (AUC) ranging from 0.84-1.00 (TAR 6 hours of antibiotic exposure) for upregulated genes and 0.57–0.90 and 0.87–1.00, respectfully, for downregulated genes. This work desmonstrates that transcriptomics allows for the assessment of antibiotic activity in Mtb within 6 hours of exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, Massachusetts, USA.
- Department of Medicine and Department of Anatomic and Clinical Pathology, Tufts University School of Medicine, Boston, Massachusetts, USA.
- Stuart B. Levy Center for Integrated Management of Antimicrobial Resistance, Boston, Massachusetts, USA.
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
- Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.
- Harvard College, Cambridge, Massachusetts, USA.
ORCID-Profile: Husain Poonawala, Daniela Maria Cirillo, Federico Di Marco, Paolo Miotto, Maha R Farhat
Förderung
- NIAID NIH HHS
- NCATS NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases
- EC | Seventh Framework Programme
- HHS | NIH | National Center for Advancing Translational Sciences
Zitieren
APA
Poonawala, H., Zhang, Y., Kuchibhotla, S., Green, A. G., Cirillo, D. M., Di Marco, F., Spitlaeri, A., Miotto, P., & Farhat, M. R. (2024). Transcriptomic responses to antibiotic exposure in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01185-23
Vancouver
Poonawala H, Zhang Y, Kuchibhotla S, Green AG, Cirillo DM, Di Marco F, et al. Transcriptomic responses to antibiotic exposure in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.01185-23
BibTeX
@article{Poonawala2024,
author = {Poonawala, Husain and Zhang, Yu and Kuchibhotla, Sravya and Green, Anna G and Cirillo, Daniela Maria and Di Marco, Federico and Spitlaeri, Andrea and Miotto, Paolo and Farhat, Maha R},
title = {Transcriptomic responses to antibiotic exposure in Mycobacterium tuberculosis},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
doi = {10.1128/aac.01185-23}
}
EUVIMED